Literature DB >> 22253422

Molecular characterization and biological function of neuroendocrine regulatory peptide-3 in the rat.

Hiroaki Fujihara1, Kazuki Sasaki, Emi Mishiro-Sato, Toyoaki Ohbuchi, Govindan Dayanithi, Motoo Yamasaki, Yoichi Ueta, Naoto Minamino.   

Abstract

Neuroendocrine regulatory peptide (NERP)-3, derived from the neurosecretory protein VGF (non-aconymic), is a new biologically active peptide identified through peptidomic analysis of the peptides secreted by an endocrine cell line. Using a specific antibody recognizing the C-terminal region of NERP-3, immunoreactive (ir)-NERP-3 was identified in acid extracts of rat brain and gut as a 30-residue NERP-3 with N-terminal pyroglutamylation. Assessed by radioimmunoassay, ir-NERP-3 was more abundant in the brain, including the posterior pituitary (PP), than in the gut. Immunohistochemistry demonstrated that ir-NERP-3 was significantly increased in the suprachiasmatic nucleus, the magnocellular division of the paraventricular nucleus, and the external layer of the median eminence, but not in the supraoptic nucleus, after dehydration. The immunoreactivity was, however, markedly decreased in all of these locations after chronic salt loading. Intracerebroventricular administration of NERP-3 in conscious rats induced Fos expression in a subset of arginine vasopressin (AVP)-containing neurons in the supraoptic nucleus and the magnocellular division of the paraventricular nucleus. On in vitro isolated rat PP preparations, NERP-3 caused a significant AVP release in a dose-related manner, suggesting that NERP-3 in the PP could be an autocrine activator of AVP release. Taken together, the present results suggest that NERP-3 in the hypothalamo-neurohypophyseal system may be involved in the regulation of body fluid balance.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22253422     DOI: 10.1210/en.2011-1539

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  7 in total

Review 1.  Physiological regulation of magnocellular neurosecretory cell activity: integration of intrinsic, local and afferent mechanisms.

Authors:  C H Brown; J S Bains; M Ludwig; J E Stern
Journal:  J Neuroendocrinol       Date:  2013-08       Impact factor: 3.627

2.  The granin VGF promotes genesis of secretory vesicles, and regulates circulating catecholamine levels and blood pressure.

Authors:  Samira Fargali; Angelo L Garcia; Masato Sadahiro; Cheng Jiang; William G Janssen; Wei-Jye Lin; Valeria Cogliani; Alice Elste; Steven Mortillo; Cheryl Cero; Britta Veitenheimer; Gallia Graiani; Giulio M Pasinetti; Sushil K Mahata; John W Osborn; George W Huntley; Greg R Phillips; Deanna L Benson; Alessandro Bartolomucci; Stephen R Salton
Journal:  FASEB J       Date:  2014-02-04       Impact factor: 5.191

Review 3.  Dendritic Release of Neurotransmitters.

Authors:  Mike Ludwig; David Apps; John Menzies; Jyoti C Patel; Margaret E Rice
Journal:  Compr Physiol       Date:  2016-12-06       Impact factor: 9.090

Review 4.  Somato-dendritic vasopressin and oxytocin secretion in endocrine and autonomic regulation.

Authors:  Colin H Brown; Mike Ludwig; Jeffrey G Tasker; Javier E Stern
Journal:  J Neuroendocrinol       Date:  2020-05-14       Impact factor: 3.870

5.  Identification and Evolutionary Analysis of Potential Candidate Genes in a Human Eating Disorder.

Authors:  Ubadah Sabbagh; Saman Mullegama; Gerald J Wyckoff
Journal:  Biomed Res Int       Date:  2016-03-21       Impact factor: 3.411

6.  Profiles of VGF Peptides in the Rat Brain and Their Modulations after Phencyclidine Treatment.

Authors:  Barbara Noli; Fabrizio Sanna; Carla Brancia; Filomena D'Amato; Barbara Manconi; Federica Vincenzoni; Irene Messana; Maria R Melis; Antonio Argiolas; Gian-Luca Ferri; Cristina Cocco
Journal:  Front Cell Neurosci       Date:  2017-06-02       Impact factor: 5.505

7.  VGF changes during the estrous cycle: a novel endocrine role for TLQP peptides?

Authors:  Barbara Noli; Carla Brancia; Filomena D'Amato; Gian-Luca Ferri; Cristina Cocco
Journal:  PLoS One       Date:  2014-10-03       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.